Avricore Health Inc. (TSXV:AVCR)
0.0650
0.00 (0.00%)
At close: Mar 19, 2026
Avricore Health Revenue
Avricore Health had revenue of 37.68K CAD in the quarter ending September 30, 2025, a decrease of -96.85%. This brings the company's revenue in the last twelve months to 1.92M, down -59.28% year-over-year. In the year 2024, Avricore Health had annual revenue of 4.79M with 37.32% growth.
Revenue (ttm)
1.92M
Revenue Growth
-59.28%
P/S Ratio
3.43
Revenue / Employee
n/a
Employees
n/a
Market Cap
6.58M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 4.79M | 1.30M | 37.32% |
| Dec 31, 2023 | 3.49M | 1.72M | 97.08% |
| Dec 31, 2022 | 1.77M | 1.65M | 1,339.95% |
| Dec 31, 2021 | 122.81K | 89.78K | 271.81% |
| Dec 31, 2020 | 33.03K | 30.00 | 0.09% |
| Dec 31, 2019 | 33.00K | 17.71K | 115.76% |
| Dec 31, 2018 | 15.30K | -2.14M | -99.29% |
| Dec 31, 2017 | 2.15M | -1.32M | -38.00% |
| Dec 31, 2016 | 3.48M | 2.76M | 384.20% |
| Dec 31, 2015 | 717.81K | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionAvricore Health News
- 2 months ago - HealthTab™ to Expand Across North East London - GlobeNewsWire
- 10 months ago - Avricore Grants Options - GlobeNewsWire
- 10 months ago - Avricore Appoints Rodger Seccombe as CEO - GlobeNewsWire
- 10 months ago - AVRICORE HEALTH CORPORATE UPDATE: Q1 Results and Ongoing Progress Report - GlobeNewsWire
- 11 months ago - AVRICORE HEALTH CORPORATE UPDATE: 2024 record year, UK expansion on track - GlobeNewsWire
- 1 year ago - HealthTab™ and Patients Know Best® Bring Pharmacy-Based Blood Test Results to Millions in UK - GlobeNewsWire
- 1 year ago - Avricore Health Corporate Update: Effective Plan, Resources Result in Success - GlobeNewsWire
- 1 year ago - Avricore Health Refocuses Strategy to Unlock Growth Potential - GlobeNewsWire